Xylem Community
Create a narrative
WA
Based on Analyst Price Targets
Evoqua Acquisition And MCS Expansion Propel Earnings And Revenue Surge
US$153.12
FV
12.4% undervalued intrinsic discount5.21%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
18 days agoauthor updated this narrative